Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason D Shields

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Organic Letters|April 18, 2015
A modular, air-stable nickel precatalystJason D Shields, Erin E Gray, Abigail G Doyle
Organic Letters|November 28, 2013
Enantioselective, nickel-catalyzed Suzuki cross-coupling of quinolinium ionsJason D Shields, Derek T Ahneman, Thomas J A Graham, et al.
Macromolecular Chemistry and Physics|September 21, 2013
Clickable Poly(ethylene glycol)-Microsphere-Based Cell ScaffoldsPeter K Nguyen, Christopher G Snyder, Jason D Shields, et al.
RSC Medicinal Chemistry|April 26, 2024
AiZynth impact on medicinal chemistry practice at AstraZenecaJason D Shields, Rachel Howells, Gillian Lamont, et al.
Journal of Medicinal Chemistry|November 14, 2024
Design and Synthesis of Acyclic Boronic Acid Arginase InhibitorsJason D Shields, Brian M Aquila, David Emmons, et al.
Journal of Medicinal Chemistry|November 22, 2024
Discovery of (2<i>R</i>,4<i>R</i>)-4-((<i>S</i>)-2-Amino-3-methylbutanamido)-2-(4-boronobutyl)pyrrolidine-2-carboxylic Acid (AZD0011), an Actively Transported Prodrug of a Potent Arginase Inhibitor to Treat CancerScott N Mlynarski, Brian M Aquila, Susan Cantin, et al.
RSC Medicinal Chemistry|June 16, 2025
Synthetic chemistry enabling the discovery and development of a series of pyrazoles as HPK1 inhibitorsAnthony J Metrano, Lucas A Morrill, Gayathri Bommakanti, et al.
Journal of Medicinal Chemistry|February 10, 2025
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 InhibitorJason D Shields, David Baker, Amber Y S Balazs, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Organic Letters|April 18, 2015
A modular, air-stable nickel precatalystJason D Shields, Erin E Gray, Abigail G Doyle
Organic Letters|November 28, 2013
Enantioselective, nickel-catalyzed Suzuki cross-coupling of quinolinium ionsJason D Shields, Derek T Ahneman, Thomas J A Graham, et al.
Macromolecular Chemistry and Physics|September 21, 2013
Clickable Poly(ethylene glycol)-Microsphere-Based Cell ScaffoldsPeter K Nguyen, Christopher G Snyder, Jason D Shields, et al.
RSC Medicinal Chemistry|April 26, 2024
AiZynth impact on medicinal chemistry practice at AstraZenecaJason D Shields, Rachel Howells, Gillian Lamont, et al.
Journal of Medicinal Chemistry|November 14, 2024
Design and Synthesis of Acyclic Boronic Acid Arginase InhibitorsJason D Shields, Brian M Aquila, David Emmons, et al.
Journal of Medicinal Chemistry|November 22, 2024
Discovery of (2<i>R</i>,4<i>R</i>)-4-((<i>S</i>)-2-Amino-3-methylbutanamido)-2-(4-boronobutyl)pyrrolidine-2-carboxylic Acid (AZD0011), an Actively Transported Prodrug of a Potent Arginase Inhibitor to Treat CancerScott N Mlynarski, Brian M Aquila, Susan Cantin, et al.
RSC Medicinal Chemistry|June 16, 2025
Synthetic chemistry enabling the discovery and development of a series of pyrazoles as HPK1 inhibitorsAnthony J Metrano, Lucas A Morrill, Gayathri Bommakanti, et al.
Journal of Medicinal Chemistry|February 10, 2025
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 InhibitorJason D Shields, David Baker, Amber Y S Balazs, et al.
Pageof 1